Erythra Inc. (Delaware file No.: 6865346) is formed around a breakthrough discovery for a new function for Red Blood cells as Antigen Transporters. The number of products that can be developed is innumerable.

The first product is a rapid test for the diagnosis and monitoring of TB in humans and bovines. This TB test has been evaluated in academia and private clinical laboratories in Egypt.

It needs FDA approval and official clinical trials.